gefitinib has been researched along with Deafness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y; Hua, GD; Huang, M; Lei, ZZ; Liang, Y; Sun, XD; Wang, JG; Wang, Y; Xue, CM; Yang, WH; Zhang, SS; Zhu, BC | 1 |
1 review(s) available for gefitinib and Deafness
| Article | Year |
|---|---|
Sensorineural hearing loss induced by gefitinib: A CARE-compliant case report and literature reviews.
Topics: Adenocarcinoma of Lung; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Deafness; ErbB Receptors; Female; Gefitinib; Hearing Loss, Sensorineural; Humans; Lung Neoplasms; Mutation | 2023 |